All filters
Slidesets
Prevalence of Mental Health and Social Well-being Issues among Pregnant Adolescent Girls and Young Women in Western Kenya - Mary Marwa, Kenya
Presented at:
International Workshop on HIV & Adolescence 2019
Slidesets
Self-disclosure of HIV Status by Adolescents and Young Adults is Associated With Higher Levels of Enacted and Internalized Stigma - Cyrus Mugo, Kenya
Presented at:
International Workshop on HIV & Adolescence 2019
Slidesets
Piloting a Psychosocial Support Program to Target Adolescent Girls and Young Women Living with HIV at Baylor-Tanzania - Nazarena Myenzi, Tanzania
Presented at:
International Workshop on HIV & Adolescence 2019
Slidesets
Improving HIV Case Identification for Adolescents and Young People through Assisted Partner Notification (APN) approach: Implementation Progress in Uganda - Taasi Geoffrey, Uganda
Presented at:
International Workshop on HIV & Adolescence 2019
Slidesets
Thetha Nami: Implementation and Early Lessons Learnt from a Peer-Support Program to Improve Uptake and Retention in Multi-Level HIV Prevention for Adolescent Girls and Young Women in Rural South Africa - Sakhile Mdluli, South Africa
Presented at:
International Workshop on HIV & Adolescence 2019
Slidesets
Cost-Effectiveness of a Combination Intervention to Improve Retention and Viral Suppression among HIV-Positive Adolescents in Kenya: The ACT Adolescent Project Study - Maryanne Ombija, USA
Presented at:
International Workshop on HIV & Adolescence 2019
Slidesets
Simplification of Drug Regimens - Pedro Cahn, MD, PhD
Presented at:
Belem HIV Clinical Forum 2019
Slidesets
Pharmacology Considerations When Choosing INSTIs - Charles Flexner, MD
Presented at:
Belem HIV Clinical Forum 2019
Slidesets
Clinical Case - Gustavo Albino Pinto Magalhães, MD, PhD
Presented at:
Belem HIV Clinical Forum 2019
Slidesets
Resistance Considerations When Choosing INSTIs - Charles Boucher, MD, PhD
Presented at:
Belem HIV Clinical Forum 2019
Slidesets
Experience with Dolutegravir in First Line in Brazil - Ricardo Diaz, MD
Presented at:
Belem HIV Clinical Forum 2019
Slidesets
INSTIs Use in Women at Child-Bearing Age - NTD Risks - Sharon Walmsley, FRCPC, MD, MSC
Presented at:
Belem HIV Clinical Forum 2019
Slidesets
Role of INSTIs in Prevention - Mauro Schechter, MD, PhD
Presented at:
Belem HIV Clinical Forum 2019
Slidesets
Clinical Management of HIV-TB Co-Infected Patients - Mark Nelson, MD
Presented at:
Belem HIV Clinical Forum 2019
Slidesets
Clinical Case - Maria do Perpetuo Socorro Costa Correa, MD
Presented at:
Belem HIV Clinical Forum 2019
Slidesets
Switching to INSTIs Based Treatment in Viral Suppressed Patients - Mark Nelson, MD
Presented at:
Belem HIV Clinical Forum 2019
Slidesets
PrEP in young: does the incidence of STI increase? - José Valdez Madruga, MD
Presented at:
Belem HIV Clinical Forum 2019
Slidesets
Pharmacology Considerations When Choosing INSTIs - David Back, PhD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
Toxicity Considerations When Choosing INSTIs - Ian Frank, MD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
Resistance to INSTIs and How Resistance Impacts Treatment Choices - Charles Boucher, MD, PhD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
Experience with Dolutegravir in First-Line in Brazil - Ricardo Diaz, MD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
Switching to INSTI-Based Treatment in Viral Suppressed Patients - Ian Frank, MD
Presented at:
Salvador HIV Clinical Forum 2019
Slidesets
Role of INSTIs in HIV Prevention - Mauro Schechter, MD, PhD
Presented at:
Salvador HIV Clinical Forum 2019